Sterling Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Sterling Capital Management's ASND Position: Q3 2026 in Review
Sterling Capital Management reduced its Ascendis Pharma (ASND) stake by 29% in Q3 2026, selling an estimated $1.02M and leaving 9,690 shares worth $2.21M. The position accounts for 0.04% of the portfolio, ranked #304.
Sterling Capital Management first reported a position in ASND in Q1 2015 and has held it in 13 quarters since. The position peaked at $9.41M in Q2 2025. 275 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Sterling Capital Management held 9,690 shares of Ascendis Pharma worth $2.21M as of Q3 2026.
- Sterling Capital Management sold 4,037 Ascendis Pharma shares in Q3 2026, an estimated $1.02M.
- Ascendis Pharma made up 0.04% of Sterling Capital Management's portfolio in Q3 2026, its #304 holding.
- Sterling Capital Management first reported a position in Ascendis Pharma in Q1 2015 and has held it in 13 quarters since.
- Sterling Capital Management's Ascendis Pharma position peaked at $9.41M in Q2 2025.
- 275 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.